Novo Ventures co-leads US $83m series C financing in Lava Therapeutics
New investment to support advancement of powerful bispecific Gamma-Delta T cell engager programs for the treatment of a broad range of cancers Leading global life sciences venture has invested approx US$1 billion in last two years COPENHAGEN, Denmark... Biopharmaceuticals, Oncology, Venture Capital Novo Ventures, LAVA Therapeutics, gamma-delta T cells (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2020 Category: Pharmaceuticals Source Type: news

Signifier Medical Technologies Closes $10M Series C Funding Round
BOSTON and LONDON, Sept. 16, 2020 -- (Healthcare Sales & Marketing Network) -- Signifier Medical Technologies ("Signifier"), an innovator in the sleep disordered breathing market, today announced it has closed a circa $10M Series C funding round... Devices, Venture Capital Signifier Medical Technologies, obstructive sleep apnea, neurostimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 16, 2020 Category: Pharmaceuticals Source Type: news

McKesson Ventures Grows Leadership Team with New Partner Promotions
SAN FRANCISCO —Sept. 16, 2020—McKesson Ventures, the venture capital arm of McKesson Corporation, announces the expansion of its leadership team, promoting Jennifer Carter and Carrie Hurwitz Williams to partners of McKesson Ventures. The new partner roles exemplify McKesson Ventures’ growth since it ... (Source: McKesson News)
Source: McKesson News - September 16, 2020 Category: Information Technology Source Type: news

ControlRad(R) Announces FDA Clearance and Closing of Series C Financing
ATLANTA, Sept. 15, 2020 -- (Healthcare Sales & Marketing Network) -- ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, today announced t... Devices, Radiology, Venture Capital, FDA ControlRad, ControlRad Trace (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2020 Category: Pharmaceuticals Source Type: news

Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis
Leverages proprietary pan-amyloid targeting agents with potential to diagnose and reverse the underlying pathology of systemic amyloid diseases, including AL and ATTR amyloidosis SOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 -- (Healthcare Sales & Marketi... Biopharmaceuticals, Venture Capital Attralus, amyloidosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2020 Category: Pharmaceuticals Source Type: news

Adona Medical, A Shifamed Portfolio Company, Closes $22M In Series A Financing
Company to accelerate development of advanced approaches for management of heart failure CAMPBELL, Calif., Sept. 8, 2020 -- (Healthcare Sales & Marketing Network) -- Adona Medical, a Shifamed portfolio company, announced today the closing of a $22M Ser... Devices, Interventional, Cardiology, Venture Capital Adona Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2020 Category: Pharmaceuticals Source Type: news

I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium
Ordinary Share Purchase price equivalent to $33.00 per ADS, at a premium to the 30-day volume weighted average price ("VWAP") Demonstrates leading biotech investors' strong endorsement of I-Mab's R&D innovation and value generation capabilitie... Biopharmaceuticals, Venture Capital I-Mab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 4, 2020 Category: Pharmaceuticals Source Type: news

Can Platforms Help Reduce The $935 Billion In Wasteful Healthcare Spend?
The healthcare industry is particularly ripe for platforms to add value. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 3, 2020 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
Funding to advance "home hospital" initiatives with health systems and "beyond the pill" digital therapeutics partnerships with pharmaceutical companies BOSTON, Sept. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Biofourmis, ... Devices, Venture Capital Biofourmis, digital therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 3, 2020 Category: Pharmaceuticals Source Type: news

Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
MISGAV, Israel, Aug. 31, 2020 -- (Healthcare Sales & Marketing Network) -- Vessi Medical, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY) announced that it secured $1.7 million in funding for its cryoablation solution for superf... Devices, Urology, Oncology, Venture Capital Vessi Medical, cryoablation, cryo-spray ablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2020 Category: Pharmaceuticals Source Type: news

Clene Nanomedicine Raises Series D Financing of $42.5 Million
SALT LAKE CITY, Aug. 26, 2020 -- (Healthcare Sales & Marketing Network) -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D financing. The round was led by SymBiosis II, ... Biopharmaceuticals, Neurology, Venture Capital Clene Nanomedicine, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 26, 2020 Category: Pharmaceuticals Source Type: news

Phosplatin Therapeutics Completes $18.4 Million Private Financing Round
Proceeds to be used for completion of Phase 2 clinical proof of concept studies for lead candidate PT-112 NEW YORK, Aug. 26, 2020 -- (Healthcare Sales & Marketing Network) -- Phosplatin Therapeutics LLC, a clinical stage pharmaceutical company focused ... Biopharmaceuticals, Oncology, Venture Capital Phosplatin Therapeutics, phosphaplatins (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 26, 2020 Category: Pharmaceuticals Source Type: news

DiscGenics Raises $50 Million in Series C Funding
SALT LAKE CITY, Aug. 25, 2020 -- (Healthcare Sales & Marketing Network) -- DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative dis... Regenerative Medicine, Orthopaedic, Venture Capital DiscGenics, Discogenic Cells (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 25, 2020 Category: Pharmaceuticals Source Type: news

Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs
In an oversubscribed round, top-tier investors provide significant financial resources to accelerate clinical development of potentially best-in-class therapies for inflammatory/autoimmune diseases SAN DIEGO and TAICANG, SUZHOU, China, Aug. 24, 2020 -- ... Biopharmaceuticals, Venture Capital, Personnel Connect Biopharma, atopic dermatitis, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 24, 2020 Category: Pharmaceuticals Source Type: news

LensGen(R) Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directors
IRVINE, Calif., Aug. 20, 2020 -- (Healthcare Sales & Marketing Network) -- LensGen, Inc., an ophthalmic medical device company and developer of Juvene®, a disruptive fluid-optic intraocular lens (IOL) for cataract and presbyopia treatment, announces t... Devices, Ophthalmology, Venture Capital, Personnel LensGen, Juvene, intraocular lens, presbyopia, cataract (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 20, 2020 Category: Pharmaceuticals Source Type: news

Garwood Medical Devices Announces Series C Funding
BUFFALO, N.Y., Aug. 20, 2020 -- (Healthcare Sales & Marketing Network) -- Garwood Medical Devices, a leader in groundbreaking medical device technology, today announced a Series C financing round of $4 million to support additional preclinical testing fo... Devices, Venture Capital Garwood Medical Devices, BioPrax (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 20, 2020 Category: Pharmaceuticals Source Type: news

Airbnb Confidentially Files IPO Paperwork
Airbnb has resumed its efforts to go public this year, despite fallout from the pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 19, 2020 Category: Pharmaceuticals Authors: Sergei Klebnikov, Forbes Staff Tags: Markets /markets Money /money Business /business Real Estate /real-estate Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Consumer Tech /consumer-tech Lifestyle /lifestyle Travel /travel Source Type: news

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing
Company is creating innovative cellular therapeutics for solid tumors CAMARILLO, Calif., Aug. 18, 2020 -- (Healthcare Sales & Marketing Network) -- ImmPACT Bio USA Inc., a company founded in the FutuRx incubator located in Ness Ziona, Israel, developin... Biopharmaceuticals, Oncology, Venture Capital ImmPACT Bio USA, cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 18, 2020 Category: Pharmaceuticals Source Type: news

Duke-NUS spinout PairX Bio launches with strong biotech credentials, VC backing
(Duke-NUS Medical School) Duke-NUS spinout company, PairX, led by seasoned US and Singapore scientists and financiers with strong track records in biotech startups, venture capital and investment, aims to advance innovative biotechnology built on deep expertise in mRNA splicing biology and a proprietary immunotherapy platform exclusively licensed from Duke-NUS Medical School. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2020 Category: International Medicine & Public Health Source Type: news

Micronoma Launches with $3 Million Seed Funding
First early cancer-detection company to use microbial biomarkers in diagnostics SAN DIEGO, Aug. 13, 2020 -- (Healthcare Sales & Marketing Network) -- Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invas... Diagnostics, Oncology, Venture Capital Micronoma, microbiome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 13, 2020 Category: Pharmaceuticals Source Type: news

MobileODT completed $4 million series round C
The round will support the development of AI cervical cancer screening device TEL AVIV, Israel, Aug. 12, 2020 -- (Healthcare Sales & Marketing Network) -- MobileODT, the developer of the EVA System for cervical cancer screening, announced the completio... Diagnostics, Oncology, Venture Capital MobileODT, EVA System, VisualCheck, cervical cancer screening (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 12, 2020 Category: Pharmaceuticals Source Type: news

Airbnb Reportedly To File IPO Paperwork Later This Month
Airbnb has resumed its efforts to go public this year, despite fallout from the pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 11, 2020 Category: Pharmaceuticals Authors: Sergei Klebnikov, Forbes Staff Tags: Markets /markets Money /money Business /business Real Estate /real-estate Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Consumer Tech /consumer-tech Lifestyle /lifestyle Travel /travel Source Type: news

Wouter Meuleman Promoted to Partner of Illumina Ventures
FOSTER CITY, Calif., Aug. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, Inc. (NASDAQ: ILMN), today announced the promotion of Wo... Biopharmaceuticals, Diagnostics, Venture Capital, Personnel Illumina Ventures, genomics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 11, 2020 Category: Pharmaceuticals Source Type: news

Northwestern Mutual invests in Dallas health startup targeting millennials
Northwestern Mutual Future Ventures, the venture arm of Milwaukee-based financial services and life insurance company Northwestern Mutual, is investing in a Dallas health startup focused on millennials. Mountain Health Technologies, recently closed on $1.6 million in funding, according to a filing with the U.S. Securities and Exchange Commission. The round was led by Matchstick Ventures, a venture capital firm founded by two Techstars Ventures managing directors, and with participation from Techs tars,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 29, 2020 Category: Biotechnology Authors: Brian Womack Source Type: news

Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases
AON-platform with focus on therapies nearing phase I trials for forms of Spinocerebellar Ataxia and Huntington Disease Other early discovery stage RNA editing platform focuses on RETT syndrome Funding led by LSP, co-led by Kurma Partners, supported b... Biopharmaceuticals, Neurology, Venture Capital Vico Therapeutics, RNA modulating therapies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 29, 2020 Category: Pharmaceuticals Source Type: news

New investors boost cancer blood-testing firm ’s $257M Series B round
A Cambridge startup developing a blood test to better detect early cancer has raised new venture capital funding as it mulls an early product launch.   Thrive Earlier Detection Corp. raised $257 million in new financing this week. At least 11 new investors, including Bain Capital Life Sciences, contributed to the Series B funding round alongside existing investors. Thrive launched early last year with $110 million in Series A funding, which wa s one of the biggest Series A rounds at the time (a… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Telehealth Startup Ro Is Now Valued At $1.5 Billion After Closing $200 Million Funding Round
Ro says it has facilitated more than 5 million digital healthcare visits for patients in nearly every county in the U.S., including 98% of primary care deserts, since it was founded in 2017. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 27, 2020 Category: Pharmaceuticals Authors: Elana Lyn Gross, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Breaking breaking-news Billionaires Source Type: news

Practicing Medicine In The Era Of Private Equity, Venture Capital, And Public Markets
This change in ownership of healthcare delivery firms creates a new operating reality where the previous central tenet of healthcare delivery —doing what is best for the patient—now has a competing imperative: doing what is best for shareholders and investors. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 27, 2020 Category: Pharmaceuticals Authors: Sachin H. Jain, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital business pharma Source Type: news

Practicing Medicine In The Era Of Private Equity, Venture Capital And Public Markets
This change in ownership of healthcare delivery firms creates a new operating reality where the previous central tenet of healthcare delivery —doing what is best for the patient—now has a competing imperative: doing what is best for shareholders and investors. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 27, 2020 Category: Pharmaceuticals Authors: Sachin H. Jain, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital business pharma Source Type: news

Olema Oncology Announces $54 Million Series B Financing
Proceeds will be used to advance lead program in breast cancer into Phase 1/2 clinical development Financing co-led by BVF Partners L.P., Logos Capital and Janus Henderson Investors SAN FRANCISCO, July 22, 2020 -- (Healthcare Sales & Marketing Networ... Biopharmaceuticals, Oncology, Venture Capital, Personnel Olema Oncology, complete estrogen receptor antagonist, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2020 Category: Pharmaceuticals Source Type: news

Fund managed out of Boston leads $40M investment into Ohio gene therapy startup
A gene therapy startup in Grove City has raised $40 million in venture capital to both bring biotech to market and manufacture genetic material for outside clients. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 22, 2020 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news

Shanghai Drug Maker Gets $97 Mln From Fidelity, GIC, Qiming, Others
The Covid-19 pandemic has put China's pharmaceutical, medical an healthcare industries in the global spotlight. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 20, 2020 Category: Pharmaceuticals Authors: Russell Flannery, Forbes Staff Tags: Asia /asia Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital russellflanneryblog Source Type: news

Imvax Inc. Raises $112 Million in Series C Financing
Funds to support Phase 2 Clinical Development of IGV-001 for treatment of Glioblastoma multiforme, Phase 1 research into additional solid tumor indications and build out of the operational capabilities PHILADELPHIA, July 16, 2020 -- (Healthcare Sales & ... Biopharmaceuticals, Oncology, Venture Capital Imvax Inc, neo-antigen immunotherapy, glioblastoma multiforme (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 16, 2020 Category: Pharmaceuticals Source Type: news

The Record-Breaking Biotech Funding Tsunami Of 1H2020
Biotech equity funding across venture capital and the public markets reached record-breaking levels in 2Q 2020 (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 15, 2020 Category: Pharmaceuticals Authors: Bruce Booth, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Medly Pharmacy raises $100 million in a Series B funding round
Digital pharmacy Medly Pharmacy said it's raised $100 million in a Series B round of funding. The Brooklyn, New York-based company said the funding round was co-led by Boston growth equity firm Volition Capital and venture capital firm Greycroft with participation from Horsley Bridge and Lerer Hippeau. The 3-year-old company said it will use the funding "to expand its platform, enter new markets, and provide category-leading services to patients and partners across the country." "We continue… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 14, 2020 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

Platforms And Pandemics: Embracing Digital Health Platform Disruption In The Covid-19 Era
Of the key lessons that Covid-19 has served up on a silver platter, one of the clearest takeaways is that the U. S. healthcare system is not set up to handle a public health pandemic like the novel coronavirus. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 14, 2020 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Editors' Pick editors-pick Decision Maker decision-maker Coronavirus Source Type: news

Digital Pharmacy Truepill Raises $25 Million To Expand Telehealth Offerings As Revenue Could Reach $200 Million This Year
Covid-19 is shaking up how patients and insurers alike view telemedicine. Tech-enabled pharmacy startup raised $25 million from Optum Ventures and others to take advantage of that shift. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 8, 2020 Category: Pharmaceuticals Authors: Amy Feldman, Forbes Staff Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Small Business /small-business Entrepreneurs /entrepreneurs Editors' Pick editors-pick Source Type: news

LumiThera Closes Series C Round of Financing
SEATTLE, July 8, 2020 -- (Healthcare Sales & Marketing Network) -- LumiThera Inc., a commercial stage private medical device company, creating a multi-wavelength photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has ... Devices, Ophthalmology, Venture Capital LumiThera , photobiomodulation, Diabetic Retinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 8, 2020 Category: Pharmaceuticals Source Type: news

inHEART Raises $4.2 Million to Improve Treatments for Cardiac Arrhythmias With Medical Imaging, Artificial Intelligence and Numerical Simulations
PESSAC, France, July 2, 2020 -- (Healthcare Sales & Marketing Network) -- inHEART, providing a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a round of EUR 3.7 million led by Elaia. These fu... Devices, Cardiology, Venture Capital inHEART, cardiac modeling (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 2, 2020 Category: Pharmaceuticals Source Type: news

Poseida Therapeutics Raises $110 Million in Series D Financing
SAN DIEGO, June 25, 2020 -- (Healthcare Sales & Marketing Network) -- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene ... Biopharmaceuticals, Oncology, Venture Capital Poseida Therapeutics, piggyBac, Cas-CLOVER, gene engineering (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2020 Category: Pharmaceuticals Source Type: news

Enterome Completes €46.3 Million ($52.6 Million) Financing to Progress the Clinical Development of Its Therapeutic Pipeline
Lead 'OncoMimics' candidate EO2401 planned to start first clinical trials for Glioblastoma and Adrenal Tumors during mid-2020 PARIS and CAMBRIDGE, Massachusetts, June 25, 2020 -- (Healthcare Sales & Marketing Network) -- ENTEROME SA, a clinical-stage b... Biopharmaceuticals, Oncology, Venture Capital Enterome, microbiome-immunoinflammation, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2020 Category: Pharmaceuticals Source Type: news

PatientPing just announced a $60M round from over a year ago. Here's why.
In the world of venture capital-backed companies, holding the announcement of a new round for days or even weeks is not unusual. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 18, 2020 Category: Pharmaceuticals Authors: Lucia Maffei Source Type: news

Proprio Raises $23 Million in Series A Funding Led by DCVC
Company on Track to Deliver Groundbreaking Surgical Navigation System SEATTLE, June 17, 2020 -- (Healthcare Sales & Marketing Network) -- Proprio, the surgical navigation company, today announced a $23M Series A financing round led by DCVC (Data Collec... Devices, Surgery, Venture Capital Proprio, surgical navigation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 17, 2020 Category: Pharmaceuticals Source Type: news

Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
SAN DIEGO, June 16, 2020 -- (Healthcare Sales & Marketing Network) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, includi... Biopharmaceuticals, Oncology, Venture Capital Cardiff Oncology, Onvansertib, Colorectal Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2020 Category: Pharmaceuticals Source Type: news

GlySens Incorporated Closes Incremental $15 Million Financing Supporting On-Going Clinical Evaluations and First-in-Man Study of the Third Generation Eclipse(R) 3 ICGM(R) System
SAN DIEGO, June 12, 2020 -- (Healthcare Sales & Marketing Network) -- GlySens Incorporated announced today that the company has closed on an incremental $15M financing. The round was led by previous lead investors, McNair Interests and The Sarofim Group. ... Devices, Endocrinology, Monitoring, Venture Capital GlySens , glucose monitoring, Eclipse 3 ICGM (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2020 Category: Pharmaceuticals Source Type: news

HistoSonics Announces $40 Million Financing
Breakthrough medical platform offers vision of non-invasive procedures to eliminate diseased tissues and tumors MINNEAPOLIS, June 8, 2020 -- (Healthcare Sales & Marketing Network) -- HistoSonics, developer of a non-invasive robotic platform and sonic b... Devices, Venture Capital HistoSonics, histotripsy, sonic beam therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 8, 2020 Category: Pharmaceuticals Source Type: news

Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
TEL AVIV, Israel, June 4, 2020 -- (Healthcare Sales & Marketing Network) -- Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased to announce the closing of a Series B equity financing of $26 million. Inves... Devices, Oncology, Venture Capital Alpha Tau Medical, alpha-radiation, Alpha DaRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2020 Category: Pharmaceuticals Source Type: news

Novo Ventures Leads US$55M Series B Investment in NodThera
Leading global life sciences venture investors Approx US$1 billion invested in last two years COPENHAGEN, Denmark, June 3, 2020 -- (Healthcare Sales & Marketing Network) -- Novo Ventures, part of Novo Holdings, today announced that it has led the $5... Biopharmaceuticals, Venture Capital Novo Ventures, NodThera , inflammasome inhibitors (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 3, 2020 Category: Pharmaceuticals Source Type: news

OurCrowd To Raise $100 Million For Pandemic Innovation Fund Investing In Y-Shaped Recovery
OurCrowd announced today it plans to raise $100 million for its new Pandemic Innovation Fund (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 2, 2020 Category: Pharmaceuticals Authors: Gil Press, Senior Contributor Tags: Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Editors' Pick editors-pick Big Data Source Type: news

No child left behind: Startup snares $60M to target childhood cancers
Julie Grant knew the big number: While more than 200 cancer drugs were approved by the Food and Drug Administration over the past two decades, less than 10 have been OK'd for children with cancer. So when Dr. Sam Blackman, a pediatric oncologist by training and a longtime biopharmaceutical executive, walked into Grant's offices at venture capital firm Canaan Partners with an idea for a new cancer company, Grant was ready, according to Endpoints news. Ultimately the pair created Day One Biop harmaceuticals,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 21, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news